A Systematic Review Summarizing the State of Evidence on Bullying in Childhood Cancer Patients/Survivors

Background: One in four school-aged children is bullied. However, the risk may be greater for childhood cancer patients/survivors (diagnosed <18 years), because of symptoms of the disease and treatment that may prejudice peers. While the serious consequences of bullying are well documented in the general population, bullying may have even greater impact in children with cancer due to the myriad of challenges associated with treatment and prolonged school absence. Objective: To summarize the state of evidence on bullying in childhood cancer patients/survivors; specifically, the rate and types of bullying experienced and the associated factors. Method: We searched five electronic databases from inception to February 2018 for original research articles reporting on bullying in childhood cancer patients/survivors. Results: We identified 29 eligible articles, representing 1,078 patients/survivors ( M = 14.35 years). Self-reports from patients/survivors revealed a considerably higher rate of bullying (32.2%) compared with the general population (25%). Our review identified little information on the factors associated with bullying in patients/survivors. However, the bullying described tended to be verbal and was often related to the physical side effects of treatment, indicating that differences in appearance may prejudice peers. It was further suggested that educating the child’s classmates about cancer may prevent bullying. Conclusions: Our findings confirm that bullying is a significant challenge for many childhood cancer patients/survivors. Additional studies are needed to identify factors that may influence the risk of bullying, which will inform the development of evidence-based interventions and guidelines to prevent bullying in childhood cancer patients/survivors.

Download Full-text

Varicella in Children With Cancer: Seventy-Seven Case

PEDIATRICS ◽

10.1542/peds.56.3.388 ◽

1975 ◽

Vol 56 (3) ◽

pp. 388-397 ◽

Cited By ~ 2

Author(s):

Sandor Feldman ◽

Walter T. Hughes ◽

C. B. Daniel

Keyword(s):

Mortality Rate ◽

General Population ◽

Childhood Cancer ◽

Cancer Patients ◽

Anticancer Therapy ◽

Children With Cancer ◽

Acute Encephalitis

The purpose of this study was to characterize varicella in childhood cancer patients. Seventeen of the 77 patients reviewed were in remission and off all therapy for 3 to 22 months. No one in this group died from varicella or had evidence of visceral dissemination. Among the remaining 60 patients, all of whom were receiving anticancer therapy when they developed vancella, 19 (32%) had visceral dissemination and 4 died, for a mortality rate of 7%. Each of the deaths was associated with primary varicella pneumonitis, with or without acute encephalitis. Visceral dissemination was not related to type or status of malignancy or to duration of specific anticancer therapy. Varicella was more likely to disseminate in children with absolute lymphopenia, less than 500 cells per cubic millimeter, than in patients with higher lymphocyte counts. Cessation of anticancer therapy prior to the onset of lesions appeared to lessen the risk of dissemination. These results show that varicella is more severe in cancer patients on therapy than in the general population or in patients who have completed therapy, but is not highly fatal.

Download Full-text

The Epidemiology of Cancer-Associated Venous Thromboembolism: An Update

Seminars in Thrombosis and Hemostasis ◽

10.1055/s-0039-1688494 ◽

2019 ◽

Vol 45 (04) ◽

pp. 321-325 ◽

Cited By ~ 11

Author(s):

Anjlee Mahajan ◽

Ann Brunson ◽

Richard White ◽

Ted Wun

Keyword(s):

Venous Thromboembolism ◽

General Population ◽

Cancer Patients ◽

Race And Ethnicity ◽

Cancer Type ◽

Recurrent Thrombosis ◽

Factors Associated ◽

Cancer Associated Thrombosis

AbstractThe incidence of venous thromboembolism (VTE) is known to be higher in patients with malignancy as compared with the general population. It is important to understand and review the epidemiology of VTE in cancer patients because it has implications regarding treatment and prognosis. Multiple studies have shown that cancer patients who develop VTE are at higher risk for mortality. This article will focus on an update regarding the epidemiology of cancer-associated thrombosis (CT). The authors will describe factors associated with CT risk including cancer type and stage at the time of diagnosis, race and ethnicity, and cancer-directed therapy. In addition, recurrent thrombosis and the effect of thromboembolism on survival in cancer patients will also be addressed.

Download Full-text

Evidence-based psychosocial intervention for families with childhood cancer patients

10.5353/th_b4462569 ◽

2010 ◽

Author(s):

Yin-ching Luk

Keyword(s):

Childhood Cancer ◽

Cancer Patients ◽

Psychosocial Intervention ◽

Evidence Based

Download Full-text

Awareness, Knowledge, Perceived Benefits, and Barriers Regarding Precision Medicine and Willingness to Participate in a National Registry: Comparison of Cancer Patients and the General Population

10.21203/rs.3.rs-289894/v1 ◽

2021 ◽

Author(s):

Mangyeong Lee ◽

Juhee Cho ◽

Sun-Young Kong ◽

Junghee Yoon ◽

Danbee Kang ◽

...

Keyword(s):

General Population ◽

Precision Medicine ◽

Cancer Patients ◽

National Registry ◽

Willingness To Participate ◽

Perceived Benefits ◽

Cross Sectional Survey ◽

Factors Associated ◽

Area Of Interest ◽

Correct Definition

Abstract Background Precision medicine (PM) is a growing area of interest in cancer care. However, relatively little is known about the public attitudes toward PM and the factors associated with the willingness to participate in the construction of national registries for PM. Methods A cross-sectional survey was conducted with 1,500 cancer patients and 1,496 general population in South Korea from November 2016 to February 2017. We evaluated cancer patients’ awareness, knowledge, as well as perceived benefits and barriers regarding precision medicine (PM), and their willingness to participate in a national registry for PM, compared to the general population. Logistic regression analysis was performed to identify the factors associated with the willingness to participate in a national registry for PM. Results 1,500 cancer patients and 1,496 general population were recruited for the study. Cancer patients were less likely to have heard of PM than the general population (20.0% and 33.1%, P < .001), 34.2% of the participants knew the correct definition of PM. Cancer patients were more likely to However, fewer study participants in both groups said they would like to share their personal health data for PM, compared to the number of people who are willing to participate. Cancer patients (aOR 2.98, 95% CI, 2.47–3.61), participants who had heard of PM before (aOR 1.40, 95% CI, 1.00-1.95), had greater perceived benefits (aOR, 2.48, 95% CI, 1.88–3.27) and fewer perceived barriers (aOR 1.57, 95% CI, 1.18–2.08) regarding PM were more likely to have the willingness to participate in the registry compared to those who did not. Conclusions Cancer patients were more likely to have greater perceived benefits of PM and higher willingness to participate in the related study than the general population. However, both two groups were still informed about PM well. This study suggests considering the provision of information and education about PM such as expected values and required roles both to the general population and cancer patients.

Download Full-text

Palpitations in the Cancer Patient

European Cardiology Review ◽

10.15420/ecr.2021.44 ◽

2021 ◽

Vol 16 ◽

Author(s):

Hani Essa ◽

Gregory YH Lip

Keyword(s):

Primary Care ◽

Cardiovascular Diseases ◽

General Population ◽

Cancer Patient ◽

Cancer Patients ◽

Causes Of Death ◽

Evidence Based ◽

Evidence Based Guidelines ◽

Development And Management ◽

Growing Population

Cancer and cardiovascular diseases (CVD) are among the leading causes of death worldwide. In response to the growing population of cancer patients and survivors with CVD, the sub-specialty of cardio-oncology has been developed to better optimise their care. Palpitations are one of the most common presenting complaints seen in the emergency room or by the primary care provider or cardiologist. Palpitations are defined as a rapid pulsation or abnormally rapid or irregular beating of the heart and present a complex diagnostic entity with no evidence-based guidelines currently available. Palpitations are a frequent occurrence in people with cancer, and investigations and treatment are comparable to that in the general population although there are some nuances. Cancer patients are at a higher risk of arrhythmogenic causes of palpitations and non-arrhythmogenic causes of palpitations. This review will appraise the literature with regards to the development and management of palpitations in the cancer patient.

Download Full-text